Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 6.25
-0.05 (-0.79%)
Last updated: Aug 27, 2026, 12:57 PM CET
Labiana Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 76.44 | 67.37 | 59.7 | 60.76 | 59.44 | |
Revenue Growth | 13.46% | 12.86% | -1.75% | 2.21% | -1.09% |
Cost of Revenue | 32.57 | 28.47 | 27.03 | 29.99 | 26.15 |
Gross Profit | 43.87 | 38.91 | 32.67 | 30.77 | 33.29 |
Selling, General & Admin | 32.26 | 28.98 | 28.91 | 28.12 | 27.24 |
Other Operating Expenses | 0.57 | 0.59 | 0.61 | 0.04 | 0.44 |
Operating Expenses | 36.62 | 33.83 | 34.6 | 33 | 32.68 |
Operating Income | 7.26 | 5.08 | -1.92 | -2.23 | 0.61 |
Interest Expense | -5.91 | -4.84 | -3.29 | -2.11 | -2.13 |
Interest & Investment Income | 0.01 | 0.02 | 0.01 | 0.62 | 0.13 |
Currency Exchange Gain (Loss) | 0.13 | -0.07 | 0.05 | -0.13 | -0.67 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.04 | - | - |
EBT Excluding Unusual Items | 1.5 | 0.21 | -5.11 | -3.84 | -2.06 |
Gain (Loss) on Sale of Assets | - | 0.12 | -0.02 | -0.01 | 0.01 |
Asset Writedown | -0.3 | -0.36 | -0.13 | -3.99 | -0.08 |
Pretax Income | 1.2 | -0.03 | -5.27 | -7.84 | -2.12 |
Income Tax Expense | -1.36 | -0.24 | -0.78 | 1.27 | -0.01 |
Earnings From Continuing Operations | 2.55 | 0.21 | -4.49 | -9.11 | -2.11 |
Minority Interest in Earnings | 0.02 | 0.05 | 0.07 | 0.17 | 0.34 |
Net Income | 2.57 | 0.25 | -4.42 | -8.94 | -1.78 |
Net Income to Common | 2.57 | 0.25 | -4.42 | -8.94 | -1.78 |
Net Income Growth | 913.67% | - | - | - | - |
Shares Outstanding (Basic) | 7 | - | 7 | - | 6 |
Shares Outstanding (Diluted) | 7 | - | 7 | - | 6 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 0.37 | - | -0.63 | - | -0.29 |
EPS (Diluted) | 0.37 | - | -0.63 | - | -0.29 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.66 | 4.18 | -3.48 | 1.9 | 1.61 |
Free Cash Flow Per Share | -0.38 | - | -0.49 | - | 0.26 |
Gross Margin | 57.39% | 57.75% | 54.73% | 50.64% | 56.00% |
Operating Margin | 9.49% | 7.54% | -3.22% | -3.67% | 1.02% |
Profit Margin | 3.36% | 0.38% | -7.41% | -14.72% | -2.99% |
Free Cash Flow Margin | -3.48% | 6.20% | -5.84% | 3.12% | 2.71% |
EBITDA | 9.66 | 7.21 | 0.67 | 0.48 | 3.16 |
EBITDA Margin | 12.64% | 10.71% | 1.12% | 0.80% | 5.31% |
D&A For EBITDA | 2.41 | 2.13 | 2.59 | 2.71 | 2.55 |
EBIT | 7.26 | 5.08 | -1.92 | -2.23 | 0.61 |
EBIT Margin | 9.49% | 7.54% | -3.22% | -3.67% | 1.02% |
Advertising Expenses | 0.42 | 0.45 | 0.36 | 0.35 | 0.23 |